Drug Approval | April 14, 2026
FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Subscribe To Our Newsletter & Stay Updated
